Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001636642-26-000002

Chief Operating Officer gave up 32,901 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Donley Matthew Maxwell · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-20 Shares withheld for taxes : show line 1 in the form −32,901 $14.40 $473,774 662,900 D
Loading xslF345X05/wk-form4_1771880882.xml…